Articles

Applied Bio names CSO

Chief Scientific Officer leads convergence of technology, science
Written byJoanne Friedrick
| 2 min read

FOSTER CITY, Calif.—Charged with setting the scientific and technological strategy across the company, Dennis Gilbert, Ph.D., recently took on the newly created role of chief scientific officer for Applied Biosystems Group, based here.

Gilbert, who also holds the title of vice president of research for Applied Biosystems and vice president for parent company, Applera Corp., said as the company migrates from a general technology focus to a more scientific one, there was a need for a single person to manage and oversee the specific needs of customers across the company's various divisions. "We have to be concerned with not having a myopic view," says Gilbert, referring to the cross-divisional perspective.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering illustrates a sandwich ELISA technique, where antigen detection is achieved between two layers of antibodies: a capture antibody and a detection antibody
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Digital illustration of a glowing DNA double helix surrounded by interconnected circuit-like lines on a dark blue background.
Learn the key differences between chemical and enzymatic approaches to synthetic DNA production and their implications for modern research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue